QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
NASDAQ:TNYA

Tenaya Therapeutics (TNYA) Stock Price, News & Analysis

$4.46
-0.01 (-0.22%)
(As of 04:33 PM ET)
Today's Range
$4.36
$4.53
50-Day Range
$4.42
$6.80
52-Week Range
$1.66
$8.09
Volume
181,534 shs
Average Volume
576,079 shs
Market Capitalization
$350.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.40

Tenaya Therapeutics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
245.3% Upside
$15.40 Price Target
Short Interest
Bearish
4.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.03mentions of Tenaya Therapeutics in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$10 M Bought Last Quarter
Proj. Earnings Growth
Decreasing
From ($1.70) to ($1.90) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.75 out of 5 stars

Medical Sector

428th out of 930 stocks

Biological Products, Except Diagnostic Industry

61st out of 153 stocks

TNYA stock logo

About Tenaya Therapeutics Stock (NASDAQ:TNYA)

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular regeneration, and gene addition. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy which is in phase 1 clinical trial; TN-301, a small molecule for heart failure with preserved ejection fraction which is in phase 1 clinical trial; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy which is in preclinical stage. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

TNYA Stock Price History

TNYA Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
TNYA Mar 2024 7.500 put
TNYA Apr 2024 7.500 put
Tenaya Announces Pricing Of $50 Mln Underwritten Offering; Stock Up
See More Headlines
Receive TNYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tenaya Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/18/2024
Today
4/16/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:TNYA
Fax
N/A
Employees
140
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.40
High Stock Price Target
$20.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+245.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-124,080,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.05 per share

Miscellaneous

Free Float
51,954,000
Market Cap
$350.20 million
Optionable
Optionable
Beta
2.60
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Faraz Ali M.B.A. (Age 51)
    CEO, Secretary & Director
    Comp: $816.39k
  • Dr. Deepak Srivastava M.D. (Age 58)
    Scientific Founder, Chairman of Scientific Advisory Board & Director
    Comp: $118k
  • Dr. Timothy Hoey Ph.D. (Age 65)
    Chief Scientific Officer
    Comp: $573k
  • Dr. Whittemore G. Tingley M.D. (Age 56)
    PH.D., Chief Medical Officer
    Comp: $621.98k
  • Dr. Eric N. Olson Ph.D.
    Scientific Founder & Member of Scientific Advisory Board
  • Dr. Bruce R. Conklin
    Scientific Founder
  • Dr. Saptarsi Haldar M.D.
    Scientific Founder
  • Dr. Sheng Ding Ph.D.
    Scientific Founder
  • Dr. Benoit G. Bruneau Ph.D.
    Scientific Founder
  • Ms. Leone D. Patterson M.B.A. (Age 62)
    Chief Financial & Business Officer
    Comp: $448.55k

TNYA Stock Analysis - Frequently Asked Questions

Should I buy or sell Tenaya Therapeutics stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tenaya Therapeutics in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TNYA shares.
View TNYA analyst ratings
or view top-rated stocks.

What is Tenaya Therapeutics' stock price target for 2024?

7 brokers have issued twelve-month price objectives for Tenaya Therapeutics' shares. Their TNYA share price targets range from $7.00 to $20.00. On average, they anticipate the company's stock price to reach $15.40 in the next twelve months. This suggests a possible upside of 245.3% from the stock's current price.
View analysts price targets for TNYA
or view top-rated stocks among Wall Street analysts.

How have TNYA shares performed in 2024?

Tenaya Therapeutics' stock was trading at $3.24 at the start of the year. Since then, TNYA shares have increased by 37.7% and is now trading at $4.46.
View the best growth stocks for 2024 here
.

Are investors shorting Tenaya Therapeutics?

Tenaya Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 3,090,000 shares, an increase of 21.2% from the March 15th total of 2,550,000 shares. Based on an average trading volume of 609,900 shares, the short-interest ratio is presently 5.1 days. Approximately 5.0% of the shares of the stock are short sold.
View Tenaya Therapeutics' Short Interest
.

When is Tenaya Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our TNYA earnings forecast
.

How were Tenaya Therapeutics' earnings last quarter?

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) announced its earnings results on Monday, March, 18th. The company reported ($0.40) earnings per share for the quarter, beating the consensus estimate of ($0.45) by $0.05.

When did Tenaya Therapeutics IPO?

Tenaya Therapeutics (TNYA) raised $150 million in an IPO on Friday, July 30th 2021. The company issued 10,000,000 shares at $14.00-$16.00 per share.

How do I buy shares of Tenaya Therapeutics?

Shares of TNYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TNYA) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners